Researchers say study represents a resource that could also help to dissect Y-gene functions in other tissues.

In a major breakthrough, researchers in the UK have discovered a potential root cause of inflammatory bowel disease (IBD), a ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA ...

Researchers at the Crick have uncovered which genes on the Y chromosome regulate the development of sperm and impact fertility in male mice. This research could help us understand why some men don’t ...

Quotient Therapeutics, a biotech company founded in 2022, hopes to take this transatlantic model and commercialise it. Its main research lab is in Great Chesterford, a village just outside Cambridge, ...

LONDON, Jan. 22, 2025 (GLOBE NEWSWIRE) -- LinkGevity, an AI-driven drug discovery company focused on age-related diseases and longevity, today announces it has been selected for the prestigious KQ ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA can predict lung cancer outcome in a Cancer Research UK-funded study.

A study finds that a sensitive test detecting circulating tumour DNA (ctDNA) in early-stage lung cancer can predict relapse ...

London, UK-based LinkGevity today announced it has been selected for the prestigious KQ Labs Program, delivered by the Francis Crick Institute, Europe’s largest biomedical research center.

Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at London’s Francis Crick Institute and University ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumour DNA can predict lung cancer outcome in a Cancer Research UK-funded study.